The expanded lentiviral vector manufacturing plant will quadruple capacity, supporting VIVEbiotech’s cell and gene ambitions.  The contract development manufacturing organization (CDMO) said in February it would be adding 3,000 square feet to its existing facility in San Sebastian, Spain to ramp up manufacturing capacity and processes in response to lentiviral demand. The president of the Basque Government in Spain, Iñigo Urkullu and Pedro Duque, Minister of Science and Innovation of the Spanish government opened the facility on June 4. The opening ceremony…
Wednesday, June 9, 2021 Daily Archives
J&J: ‘We’re working with – but not dependent on – Emergent’
Talks are ongoing with troubled CDMO Emergent, but a robust production network means J&J is still on track to produce a billion doses of its COVID vaccine this year. In February, Johnson & Johnson (J&J) became the third firm to receive Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a COVID-19 vaccine. The single shot offering received European authorization the following month. However, the vaccine has hit several snags. Questions around potential blood clots saw…